Price $28.17 |
Market Cap
1.61B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
82.9
|
P/B
2.17
|
P/S
5.56
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
34.1
|
Op. Cash Flow
72.9K
|
FCF
0.7
|
|
Op. Margin
16.70%
|
Net Margin
7.80%
|
ROE
3.10%
|
ROI
5.90%
|
|
ROA
2.80%
|
EPS Growth
-4.80%
|
Current Ratio
6.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Lannett Company, Inc. (LCI) | $0.61 | - | - | 19.8M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.27 | - | - | 105.8M | Strong Buy |
| Akumin Inc (AKU) | $1.02 | - | - | 135.4M | Strong Buy |
| Greenrose Holding Company Inc (GNRS) | $0.37 | - | - | 18.6M | Strong Buy |
| Great Elm Group Inc (GEG) | $2.01 | - | - | 59.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
